Moracizine or moricizine

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C22H25N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2GT1D0TMX1, chemically known as phenothiazine-2-carbamic acid, 10-(3-morpholinopropionyl)-, ethyl ester but more generally known as moracizine, which bears US NIH Compound Identifier 34633. European Medicines Agency schedules Moracizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09062MIG. The term MORACIZINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules moracizine in its Anatomical Therapeutic Chemical (ATC) Classification. MORACIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, MORICIZINE remains US FDA's Preferred Term for this commodity. Moricizine bears US NLM identifiers UMLS ID C0079856 and NCI Concept Code C66196. SMILES: CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4.CL.